Hiromichi Wada

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 127 publications

The Role of VEGF-C and VEGF-D in Coronary Artery Disease: From Molecular Pathophysiology to Therapeutic Lymphangiogenesis.

The Role of VEGF-C and VEGF-D in Coronary Artery Disease: From Molecular Pathophysiology to Therapeutic Lymphangiogenesis.

Journal: Journal of atherosclerosis and thrombosis

Published: August 19, 2026

Myosin Inhibition in Non-obstructive Hypertrophic Cardiomyopathy: Lessons from ODYSSEY-HCM.

Myosin Inhibition in Non-obstructive Hypertrophic Cardiomyopathy: Lessons from ODYSSEY-HCM.

Journal: European cardiology

Published: March 25, 2026

Lipid-lowering therapy: Evidence and future perspective.

Lipid-lowering therapy: Evidence and future perspective.

Journal: JRSM cardiovascular disease

Published: March 05, 2026

Immunoglobulin free light chain-κ in association with NT-proBNP levels after smoking cessation.

Immunoglobulin free light chain-κ in association with NT-proBNP levels after smoking cessation.

Journal: Future science OA

Published: September 07, 2025

10-Year Trends of Antithrombotic Therapy Status and Clinical Outcomes in Patients With Atrial Fibrillation and Renal Dysfunction　- The Fushimi AF Registry.

10-Year Trends of Antithrombotic Therapy Status and Clinical Outcomes in Patients With Atrial Fibrillation and Renal Dysfunction　- The Fushimi AF Registry.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: October 30, 2024

Importance of non-cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction.

Importance of non-cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction.

Journal: ESC heart failure

Published: July 12, 2024

Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial.

Efficacy of highly bioavailable oral curcumin in asymptomatic or mild COVID-19 patients: a double-blind, randomized, placebo-controlled trial.

Journal: Journal of health, population, and nutrition

Published: April 25, 2024

Association of Regression from Sustained to Paroxysmal Atrial Fibrillation with Clinical Outcomes: The Fushimi AF Registry.

Association of Regression from Sustained to Paroxysmal Atrial Fibrillation with Clinical Outcomes: The Fushimi AF Registry.

Journal: The American journal of cardiology

Published: March 25, 2024

What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?

What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?

Journal: European cardiology

Published: December 11, 2023

Association of left atrial enlargement with heart failure events in non-valvular atrial fibrillation patients with preserved left ventricular ejection fraction.

Association of left atrial enlargement with heart failure events in non-valvular atrial fibrillation patients with preserved left ventricular ejection fraction.

Journal: European heart journal open

Published: November 09, 2023

Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan.

Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan.

Journal: European heart journal open

Published: September 04, 2023

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies.

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies.

Journal: European cardiology

Published: July 05, 2023

Showing 1-12 of 127

Last Updated: 09/26/2026